Ameriprise
CRDF icon

Ameriprise’s Cardiff Oncology CRDF Stock Holding History

Ameriprise’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-426
Closed -$138K – 3887
2016
Q3 		$138K Sell
426
-264
-38% -$96.2K ﹤0.01% 3622
2016
Q2 		$225K Sell
690
-14
-2% -$4.82K ﹤0.01% 3505
2016
Q1 		$236K Buy
704
+81
+13% +$27.6K ﹤0.01% 3467
2015
Q4 		$243K Buy
+623
New +$244K ﹤0.01% 3577

Other funds holding CRDF

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Ameriprise's CRDF Position: Q4 2016 in Review

Ameriprise sold out of Cardiff Oncology (CRDF) in Q4 2016, closing a stake of 426 shares — an estimated $138K sold.

Ameriprise first reported a position in CRDF in Q4 2015 and held it in 4 quarters. The position peaked at $243K in Q4 2015. 68 funds tracked by Wall St. Rank hold CRDF as of Q4 2016.

  • Ameriprise reported no remaining Cardiff Oncology position as of Q4 2016 after selling out during the quarter.
  • Ameriprise sold 426 Cardiff Oncology shares in Q4 2016, an estimated $138K.
  • Ameriprise first reported a position in Cardiff Oncology in Q4 2015 and held it in 4 quarters.
  • Ameriprise's Cardiff Oncology position peaked at $243K in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2016.

Based on Ameriprise's 13F filing for Q4 2016, filed 3 Feb 2017.